These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31870573)

  • 1. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.
    Su JR; Haber P; Ng CS; Marquez PL; Dores GM; Perez-Vilar S; Cano MV
    Vaccine; 2020 Feb; 38(7):1746-1752. PubMed ID: 31870573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics.
    Gubernot D; Menis M; Whitaker B
    Vaccine; 2023 Nov; 41(47):6922-6929. PubMed ID: 37891051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.
    Moreau JF; Watson RS; Hartman ME; Linde-Zwirble WT; Ferris LK
    Pediatr Dermatol; 2014; 31(2):163-8. PubMed ID: 23679157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
    Forman R; Koren G; Shear NH
    Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia.
    Kamaliah MD; Zainal D; Mokhtar N; Nazmi N
    Int J Dermatol; 1998 Jul; 37(7):520-3. PubMed ID: 9679693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced toxic epidermal necrolysis: A case and systematic review.
    Chahal D; Aleshin M; Turegano M; Chiu M; Worswick S
    Dermatol Online J; 2018 Jan; 24(1):. PubMed ID: 29469759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
    Lam NS; Yang YH; Wang LC; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2004 Dec; 37(6):366-70. PubMed ID: 15599469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis syndrome in patients undergoing radiation therapy: a literature review.
    Vern-Gross TZ; Kowal-Vern A
    Am J Clin Oncol; 2014 Oct; 37(5):506-13. PubMed ID: 22892429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system.
    Ball R; Ball LK; Wise RP; Braun MM; Beeler JA; Salive ME
    Pediatr Infect Dis J; 2001 Feb; 20(2):219-23. PubMed ID: 11224848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus.
    Torchia D; Romanelli P; Kerdel FA
    J Am Acad Dermatol; 2012 Sep; 67(3):417-21. PubMed ID: 22101216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema Multiforme and Epidermal Necrolysis Following COVID-19 Vaccines: A Systematic Review.
    Wu PC; Huang IH; Wang CW; Chung WH; Chen CB
    Dermatitis; 2024 Aug; ():. PubMed ID: 39172639
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
    Irwin T; Yeung CCS; Shinohara MM
    J Cutan Pathol; 2024 Jan; 51(1):76-82. PubMed ID: 37691139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome.
    Turan H; Bulbul Baskan E; Yakut T; Karkucak M; Tunali S; Saricaoglu H
    Bratisl Lek Listy; 2011; 112(5):260-3. PubMed ID: 21682079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Padniewski JJ; Jacobson-Dunlop E; Albadri S; Hylwa S
    Int J Dermatol; 2022 Aug; 61(8):923-929. PubMed ID: 35398905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.
    Morsy H; Taha EA; Nigm DA; Shahin R; Youssef EMK
    Clin Exp Dermatol; 2017 Dec; 42(8):868-873. PubMed ID: 28940568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.